The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge

Dina R. Weilhammer, Craig D. Blanchette, Nicholas O Fischer, Shabnam Alam, Gabriela G. Loots, Michele Corzett, Cynthia Thomas, Cheri Lychak, Alexis D. Dunkle, Joyce J. Ruitenberg, Smita A. Ghanekar, Andrea J. Sant, Amy Rasley

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Recent studies have demonstrated that therapies targeting the innate immune system have the potential to provide transient, non-specific protection from a variety of infectious organisms; however, the potential of enhancing the efficacy of such treatments using nano-scale delivery platforms requires more in depth evaluation. As such, we employed a nanolipoprotein (NLP) platform to enhance the efficacy of innate immune agonists. Here, we demonstrate that the synthetic Toll-like receptor (TLR) agonists monophosphoryl lipid A (MPLA) and CpG oligodeoxynucleotides (CpG) can be readily incorporated into NLPs. Conjugation of MPLA and CpG to NLPs (MPLA:NLP and CpG:NLP, respectively) significantly enhanced their immunostimulatory profiles both invitro and invivo compared to administration of agonists alone, as evidenced by significant increases in cytokine production, cell surface expression of activation markers, and upregulation of immunoregulatory genes. Importantly, enhancement of cytokine production by agonist conjugation to NLPs was also observed in primary human dendritic cells. Furthermore, BALB/c mice pretreated with CpG:NLP constructs survived a lethal influenza challenge whereas pretreatment with CpG alone had no effect on survival.

Original languageEnglish (US)
Pages (from-to)10305-10318
Number of pages14
JournalBiomaterials
Volume34
Issue number38
DOIs
StatePublished - Dec 2013
Externally publishedYes

Fingerprint

Lipids
Human Influenza
Cytokines
Oligodeoxyribonucleotides
Immune system
Toll-Like Receptors
Dendritic Cells
Immune System
Up-Regulation
Genes
Chemical activation
Survival
monophosphoryl lipid A
Therapeutics

Keywords

  • Antimicrobial
  • Drug delivery
  • Immunomodulation
  • Immunostimulation
  • Nanoparticle

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge. / Weilhammer, Dina R.; Blanchette, Craig D.; Fischer, Nicholas O; Alam, Shabnam; Loots, Gabriela G.; Corzett, Michele; Thomas, Cynthia; Lychak, Cheri; Dunkle, Alexis D.; Ruitenberg, Joyce J.; Ghanekar, Smita A.; Sant, Andrea J.; Rasley, Amy.

In: Biomaterials, Vol. 34, No. 38, 12.2013, p. 10305-10318.

Research output: Contribution to journalArticle

Weilhammer, DR, Blanchette, CD, Fischer, NO, Alam, S, Loots, GG, Corzett, M, Thomas, C, Lychak, C, Dunkle, AD, Ruitenberg, JJ, Ghanekar, SA, Sant, AJ & Rasley, A 2013, 'The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge', Biomaterials, vol. 34, no. 38, pp. 10305-10318. https://doi.org/10.1016/j.biomaterials.2013.09.038
Weilhammer, Dina R. ; Blanchette, Craig D. ; Fischer, Nicholas O ; Alam, Shabnam ; Loots, Gabriela G. ; Corzett, Michele ; Thomas, Cynthia ; Lychak, Cheri ; Dunkle, Alexis D. ; Ruitenberg, Joyce J. ; Ghanekar, Smita A. ; Sant, Andrea J. ; Rasley, Amy. / The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge. In: Biomaterials. 2013 ; Vol. 34, No. 38. pp. 10305-10318.
@article{b25f6133048d479cb01d3febf2c965c2,
title = "The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge",
abstract = "Recent studies have demonstrated that therapies targeting the innate immune system have the potential to provide transient, non-specific protection from a variety of infectious organisms; however, the potential of enhancing the efficacy of such treatments using nano-scale delivery platforms requires more in depth evaluation. As such, we employed a nanolipoprotein (NLP) platform to enhance the efficacy of innate immune agonists. Here, we demonstrate that the synthetic Toll-like receptor (TLR) agonists monophosphoryl lipid A (MPLA) and CpG oligodeoxynucleotides (CpG) can be readily incorporated into NLPs. Conjugation of MPLA and CpG to NLPs (MPLA:NLP and CpG:NLP, respectively) significantly enhanced their immunostimulatory profiles both invitro and invivo compared to administration of agonists alone, as evidenced by significant increases in cytokine production, cell surface expression of activation markers, and upregulation of immunoregulatory genes. Importantly, enhancement of cytokine production by agonist conjugation to NLPs was also observed in primary human dendritic cells. Furthermore, BALB/c mice pretreated with CpG:NLP constructs survived a lethal influenza challenge whereas pretreatment with CpG alone had no effect on survival.",
keywords = "Antimicrobial, Drug delivery, Immunomodulation, Immunostimulation, Nanoparticle",
author = "Weilhammer, {Dina R.} and Blanchette, {Craig D.} and Fischer, {Nicholas O} and Shabnam Alam and Loots, {Gabriela G.} and Michele Corzett and Cynthia Thomas and Cheri Lychak and Dunkle, {Alexis D.} and Ruitenberg, {Joyce J.} and Ghanekar, {Smita A.} and Sant, {Andrea J.} and Amy Rasley",
year = "2013",
month = "12",
doi = "10.1016/j.biomaterials.2013.09.038",
language = "English (US)",
volume = "34",
pages = "10305--10318",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "38",

}

TY - JOUR

T1 - The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge

AU - Weilhammer, Dina R.

AU - Blanchette, Craig D.

AU - Fischer, Nicholas O

AU - Alam, Shabnam

AU - Loots, Gabriela G.

AU - Corzett, Michele

AU - Thomas, Cynthia

AU - Lychak, Cheri

AU - Dunkle, Alexis D.

AU - Ruitenberg, Joyce J.

AU - Ghanekar, Smita A.

AU - Sant, Andrea J.

AU - Rasley, Amy

PY - 2013/12

Y1 - 2013/12

N2 - Recent studies have demonstrated that therapies targeting the innate immune system have the potential to provide transient, non-specific protection from a variety of infectious organisms; however, the potential of enhancing the efficacy of such treatments using nano-scale delivery platforms requires more in depth evaluation. As such, we employed a nanolipoprotein (NLP) platform to enhance the efficacy of innate immune agonists. Here, we demonstrate that the synthetic Toll-like receptor (TLR) agonists monophosphoryl lipid A (MPLA) and CpG oligodeoxynucleotides (CpG) can be readily incorporated into NLPs. Conjugation of MPLA and CpG to NLPs (MPLA:NLP and CpG:NLP, respectively) significantly enhanced their immunostimulatory profiles both invitro and invivo compared to administration of agonists alone, as evidenced by significant increases in cytokine production, cell surface expression of activation markers, and upregulation of immunoregulatory genes. Importantly, enhancement of cytokine production by agonist conjugation to NLPs was also observed in primary human dendritic cells. Furthermore, BALB/c mice pretreated with CpG:NLP constructs survived a lethal influenza challenge whereas pretreatment with CpG alone had no effect on survival.

AB - Recent studies have demonstrated that therapies targeting the innate immune system have the potential to provide transient, non-specific protection from a variety of infectious organisms; however, the potential of enhancing the efficacy of such treatments using nano-scale delivery platforms requires more in depth evaluation. As such, we employed a nanolipoprotein (NLP) platform to enhance the efficacy of innate immune agonists. Here, we demonstrate that the synthetic Toll-like receptor (TLR) agonists monophosphoryl lipid A (MPLA) and CpG oligodeoxynucleotides (CpG) can be readily incorporated into NLPs. Conjugation of MPLA and CpG to NLPs (MPLA:NLP and CpG:NLP, respectively) significantly enhanced their immunostimulatory profiles both invitro and invivo compared to administration of agonists alone, as evidenced by significant increases in cytokine production, cell surface expression of activation markers, and upregulation of immunoregulatory genes. Importantly, enhancement of cytokine production by agonist conjugation to NLPs was also observed in primary human dendritic cells. Furthermore, BALB/c mice pretreated with CpG:NLP constructs survived a lethal influenza challenge whereas pretreatment with CpG alone had no effect on survival.

KW - Antimicrobial

KW - Drug delivery

KW - Immunomodulation

KW - Immunostimulation

KW - Nanoparticle

UR - http://www.scopus.com/inward/record.url?scp=84885375018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885375018&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2013.09.038

DO - 10.1016/j.biomaterials.2013.09.038

M3 - Article

VL - 34

SP - 10305

EP - 10318

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 38

ER -